Influence of Rivastigmine transdermal on butyrylcholinesterase levels in patients with Alzheimer’s disease
Cholinesterase inhibitors (ChE-Is) are among the main drugs approved for the treatment of Alzheimer’s disease (AD). Rivastigmine in the form of a transdermal patch is an alternative delivery method, and can give greater treatment compliance. Objectives: To conduct a preliminary assessment of the neu...
שמור ב:
| הוצא לאור ב: | Dementia & Neuropsychologia |
|---|---|
| Principais autores: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Associação Neurologia Cognitiva e do Comportamento
2011
|
| נושאים: | |
| גישה מקוונת: | https://www.redalyc.org/articulo.oa?id=339529033012 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|